文献速递白内障与屈光手术

小鼠突变型αA和αB晶状体蛋白晶状体中的氧固醇化合物可改善晶状体光学特性

Oxysterol Compounds in Mouse Mutant αA- and αB-Crystallin Lenses Can Improve the Optical Properties of the Lens.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2022-01-01

研究纳入35只小鼠(野生型及Cryaa-R49C、Cryab-R120G敲入突变体),26只一眼接受局部VP1-001(氧固醇)治疗、另一眼接受溶剂对照,9只为未治疗对照;用裂隙灯生物显微镜和X射线相位断层成像评估晶状体。结果显示α晶状体蛋白突变以不同方式改变小鼠晶状体折射率梯度,局部VP1-001治疗在61%的晶状体中改善折射率轮廓,46%的活体小鼠表观晶状体混浊度降低1.0。

要点

  • 杂合Cryaa-R49C晶状体GRIN中心轮廓略不规则,前后极梯度指数明显扰动。
  • 纯合Cryab-R120G晶状体近表面轮廓更致密。
  • 局部VP1-001在61%晶状体中改善折射率轮廓,46%活体小鼠表观混浊度降低1.0。

核心结论

  • α晶状体蛋白突变以不同方式改变小鼠晶状体的折射率梯度。
  • 局部VP1-001治疗可能改善部分突变晶状体的透明度和折射率轮廓。

研究设计与样本

  • 研究纳入35只小鼠,包括野生型和Cryaa-R49C、Cryab-R120G敲入突变体。
  • 26只小鼠一眼接受局部VP1-001(氧固醇)治疗、另一眼接受溶剂,9只为未治疗对照。
  • 用裂隙灯生物显微镜分析活体晶状体并提供表观白内障分级。
  • 用基于X射线Talbot干涉仪和同步辐射源的X射线相位断层成像计算64只未固定完整小鼠眼的晶状体折射率。

主要发现

  • 杂合Cryaa-R49C晶状体GRIN中心轮廓略不规则,前后极梯度指数明显扰动。
  • 纯合Cryab-R120G晶状体近表面轮廓更致密。
  • 局部VP1-001治疗在61%的晶状体中改善折射率轮廓。
  • 局部VP1-001治疗使46%的活体小鼠表观晶状体混浊度降低1.0。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate how cataract-linked mutations affect the gradient refractive index (GRIN) and lens opacification in mouse lenses and whether there is any effect on the optics of the lens from treatment with an oxysterol compound. METHODS: A total of 35 mice including wild-type and knock-in mutants (Cryaa-R49C and Cryab-R120G) were used in these experiments: 26 mice were treated with topical VP1-001, an oxysterol, in one eye and vehicle in the other, and nine mice were untreated controls. Slit lamp biomicroscopy was used to analyze the lens in live animals and to provide apparent cataract grades. Refractive index in the lenses of 64 unfixed whole mouse eyes was calculated from measurements with X-ray phase tomography based on X-ray Talbot interferometry with a synchrotron radiation source. RESULTS: Heterozygous Cryaa-R49C lenses had slightly irregularly shaped contours in the center of the GRIN and distinct disturbances of the gradient index at the anterior and posterior poles. Contours near the lens surface were denser in homozygous Cryab-R120G lenses. Treatment with topical VP1-001, an oxysterol, showed an improvement in refractive index profiles in 61% of lenses and this was supported by a reduction in apparent lens opacity grade by 1.0 in 46% of live mice. CONCLUSIONS: These results indicate that α-crystallin mutations alter the refractive index gradient of mouse lenses in distinct ways and suggest that topical treatment with VP1-001 may improve lens transparency and refractive index contours in some lenses with mutations.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Wang K, Hoshino M, Uesugi K, et al. Oxysterol Compounds in Mouse Mutant αA- and αB-Crystallin Lenses Can Improve the Optical Properties of the Lens. Invest Ophthalmol Vis Sci. 2022. PMID: 35575904. doi:10.1167/iovs.63.5.15

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。